SOURCES SOUGHT
A -- High Performance Antigen Diagnostics
- Notice Date
- 6/17/2026 10:24:21 AM
- Notice Type
- Sources Sought
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RRPV-HPAD
- Response Due
- 7/17/2026 10:00:00 AM
- Archive Date
- 08/01/2026
- Point of Contact
- ATI
- E-Mail Address
-
rrpv@ati.org
(rrpv@ati.org)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- �High Performance Antigen Diagnostics� Request for Information (RFI) Purpose The Rapid Response Partnership Vehicle (RRPV) is issuing this Request for Information (RFI) to better understand the research, development, and product landscape of current and next-generation high performance immunoassay technologies suitable for antigen testing in near-patient settings. While conventional antigen-based immunoassays offer speed, ease of use, and low cost, they remain limited by lower analytical sensitivity and limited multiplexing capability compared to nucleic acid amplification tests (NAATs), limiting their clinical utility, particularly for early infections and syndromic panels.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/04b319ce28e94b63af8f8fa7095615ae/view)
- Place of Performance
- Address: Washington, DC, USA
- Country: USA
- Country: USA
- Record
- SN07857041-F 20260619/260617230057 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |